News

October 21, 2022

By Nuritas

Dr Brian Keogh

Brian is an immunologist with almost 20 years’ experience in the biotechnology and pharmaceutical industries. Having gained his Ph.D. from UCD under the supervision of Professors Brian Sheahan and Kingston Mills, he joined Opsona Therapeutics in 2004, where he occupied several roles. Most recently, he was the Head of In Vivo Pharmacology, leading the scientific development of a humanised monoclonal antibody against TLR2 from early-stage development to Phase II clinical trials in renal transplantation and myelodysplastic syndrome. He moved to Nuritas in 2019 where he and his team are responsible for the scientific development of a range of products from early-stage assay setup and screening to generation of clinical data for both internal pipeline and customer projects. He has over 25 publications and holds 4 patents.